Europe Launches Euro-Q-Exa Quantum Computer in Germany, Strengthening Sovereign Digital Infrastructure
12.2.2026 21:15:00 CET | Business Wire | Press release
Euro-Q-Exa will serve the scientific community and industry across Germany and Europe, enabling hands-on quantum research and application development within Europe’s HPC ecosystem. Installed, hosted, and operated at Leibniz Supercomputing Centre (LRZ), ensuring local control, operational expertise, and long-term capability building. Developed by IQM Quantum Computers using its Radiance platform, designed to enable institutions to build, operate, and evolve their own quantum capability. Engineered for deep integration with high-performance computing, supporting scalable hybrid quantum–HPC workflows. Co-funded by the EuroHPC Joint Undertaking, the German Federal Ministry of Research, Technology and Space (BMFTR), and the Bavarian State Ministry of Science and the Arts (StWK).
Euro-Q-Exa, the first EuroHPC Joint Undertaking quantum computer deployed in Germany, has been unveiled at the Leibniz Supercomputing Centre (LRZ) in Garching, Munich.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212928399/en/

Silke Launert, Parliamentary State Secretary of the BMFTR; Dieter Kranzlmüller, Director of the LRZ; Maximilian Böltl, Member of the Bavarian State Parliament; Markus Blume, Bavarian Minister of State of Science and the Arts; Henna Virkkunen, Executive Vice-President of the European Commission for Technological Sovereignty, Security and Democracy; and Sylwia Barthel de Weydenthal, Chief Commercial Officer of IQM Quantum Computers (from the left).
The deployment marks a significant step in Europe’s effort to build long-term quantum capability as part of its sovereign digital infrastructure, alongside world-leading high-performance computing (HPC).
Installed, hosted, and operated at LRZ, Euro-Q-Exa is designed not merely to provide access to quantum computing, but to enable European researchers to build, operate, and scale quantum capabilities locally. By embedding the system within an established HPC environment, the system supports the development of hands-on expertise, operational know-how, and sustainable research capacity within Europe.
Euro-Q-Exa strengthens Europe’s quantum ecosystem by enabling:
- Local capability building – Researchers operate, maintain, and evolve the system directly, developing practical expertise rather than relying on remote, black-box access.
- European IP creation and retention – algorithms, workflows, and applications developed on Euro-Q-Exa remain within European institutions, supporting long-term scientific and industrial value creation.
- Deep HPC–quantum integration – tight coupling with LRZ’s supercomputing infrastructure enables realistic hybrid quantum–classical workflows and faster progress from experimentation to application.
- Ecosystem collaboration – universities, research institutes, and industry partners share a common platform to test use cases, train talent, and build interoperable solutions.
The system is based on IQM’s Radiance platform and features 54 superconducting qubits. Euro-Q-Exa will be complemented by a second, more powerful system of 150 qubits by the end of 2026, further expanding Europe’s operational quantum capacity.
By integrating Euro-Q-Exa directly into LRZ’s supercomputing environment, European researchers can develop, test, and scale hybrid quantum–HPC applications in areas such as neurodegenerative disease research, computational pharmacology, and climate modelling. This approach allows quantum technologies to mature within operational research environments and supports their transition toward sustained scientific and industrial use.
Euro-Q-Exa is one of six quantum computers being integrated into Europe’s most advanced supercomputing centres, alongside installations in Czechia, France, Italy, Poland, and Spain, reinforcing Europe’s coordinated approach to sovereign digital infrastructure.
Henna Virkkunen, European Commission’s Executive Vice-President for Technological Sovereignty, Security and Democracy: “As the quantum market is still nascent, the European Commission is actively shaping it: Through EuroHPC, and together with Member States, we have already procured and co-funded the first six European quantum systems. Four are operational, and two more are under procurement. This is a clear demonstration of Europe’s commitment to building sovereign quantum capacity on our own continent. The Leibniz Supercomputing Centre stands as a concrete example of this ambition in action. It shows how we can successfully support and scale up leading European providers such as IQM, who are at the forefront of quantum innovation. By anchoring these systems in Europe, we are strengthening our industrial base and ensuring that strategic technologies are developed and deployed in Europe, for Europe. With the new system — and its substantial upgrade planned for early 2027 — we are already enabling complex quantum computations today. This is not a distant promise; it is operational reality.”
Markus Blume, Bavarian Minister of State of Science and the Arts: “Germany's first European quantum computer is being installed at the Leibniz Supercomputing Centre in Bavaria, which is no coincidence, but the result of our strong high-tech ecosystem. The fact is: Euro-Q-Exa is much more than just a new computer. It represents technological sovereignty and our ambition to develop our own digital infrastructure. At Germany's largest research campus in Garching, a vibrant hub for European ideas, we are combining quantum computing, supercomputing and artificial intelligence to create new dimensions in computing. This is precisely why we are also applying to host an AI gigafactory. Projects like this demonstrate Bavaria's readiness to take responsibility for Europe's digital future. Garching is sending out a strong signal: this is where the computing resources that enable innovation and strengthen our technological capabilities are being created – this is where the future is not only being conceived but also being calculated.”
Anders Dam Jansen, Executive Director EuroHPC Joint Undertaking: “The inauguration of Euro-Q-Exa represents another milestone in our journey towards a world-class European quantum computing infrastructure. This new EuroHPC quantum system reinforces our commitment to providing researchers, industry, and the public sector with cutting-edge computational resources, fostering innovation and technological sovereignty across Europe.”
Prof. Dieter Kranzlmüller, Chairman of the Board of Directors, LRZ: “With Euro-Q-Exa, we are combining the strengths of quantum and supercomputing. This gives researchers the opportunity to test new approaches and implement groundbreaking calculations, opening up new scientific dimensions using European technology. Here at LRZ, we are looking forward to embarking on some exciting research projects and gaining new insights.”
Dr Jan Goetz, CEO of IQM Quantum Computers: “The countries that own their open quantum infrastructure, not just access to the cloud will lead. Europe is building toward that: locally operated systems, education of the new generation, hybrid HPC integration, and the institutional expertise that only comes from ownership.”
About IQM Quantum Computers:
IQM is a global leader in superconducting quantum computers. IQM provides both on-premises full-stack quantum computers and a cloud platform to access its systems. IQM customers include leading high-performance computing centres, research laboratories, universities, and enterprises that require full access to quantum hardware and software. IQM has over 300 employees, with headquarters in Finland and a global presence in France, Germany, Italy, Japan, Poland, Spain, Singapore, South Korea, and the United States.
About the Leibniz Supercomputing Centre (LRZ):
For over 60 years, the Leibniz Supercomputing Centre (LRZ) has been one of Europe’s leading high-performance computing centres, providing advanced digital infrastructure to a broad scientific community across disciplines including engineering, life sciences, physics, and digital humanities. Located in Garching near Munich, LRZ operates national and European-scale supercomputing systems and supports users with deep expertise in HPC application development, portability, and scalability. LRZ is actively shaping the future of digital infrastructure by integrating emerging technologies, including quantum computing.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260212928399/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom